
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Identification of a Gut Commensal That Compromises the Blood Pressure-Lowering Effect of Ester Angiotensin-Converting Enzyme Inhibitors
Tao Yang, Xue Mei, Ethel Tackie‐Yarboi, et al.
Hypertension (2022) Vol. 79, Iss. 8, pp. 1591-1601
Open Access | Times Cited: 31
Tao Yang, Xue Mei, Ethel Tackie‐Yarboi, et al.
Hypertension (2022) Vol. 79, Iss. 8, pp. 1591-1601
Open Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
The gut microbiome and hypertension
Joanne A. O’Donnell, Tenghao Zheng, Guillaume Méric, et al.
Nature Reviews Nephrology (2023) Vol. 19, Iss. 3, pp. 153-167
Closed Access | Times Cited: 134
Joanne A. O’Donnell, Tenghao Zheng, Guillaume Méric, et al.
Nature Reviews Nephrology (2023) Vol. 19, Iss. 3, pp. 153-167
Closed Access | Times Cited: 134
Gut microbiota dependant trimethylamine N-oxide and hypertension
Katongo Hope Mutengo, Sepiso K. Masenga, Aggrey Mweemba, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 23
Katongo Hope Mutengo, Sepiso K. Masenga, Aggrey Mweemba, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 23
The oral microbiome of patients with ischemic stroke predicts their severity and prognosis
Wenbo Sun, Shengwen Huang, Xiaoli Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
Wenbo Sun, Shengwen Huang, Xiaoli Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
Prospects for Leveraging the Microbiota as Medicine for Hypertension
David J. Durgan, Jasenka Zubcevic, Matam Vijay–Kumar, et al.
Hypertension (2024) Vol. 81, Iss. 5, pp. 951-963
Open Access | Times Cited: 7
David J. Durgan, Jasenka Zubcevic, Matam Vijay–Kumar, et al.
Hypertension (2024) Vol. 81, Iss. 5, pp. 951-963
Open Access | Times Cited: 7
Untapped potential of gut microbiome for hypertension management
Kan Gao, Pu Xiu Wang, Xue Mei, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 7
Kan Gao, Pu Xiu Wang, Xue Mei, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 7
Intestinal microbiota by angiotensin receptor blocker therapy exerts protective effects against hypertensive damages
Jing Li, Siyuan Wang, Kaixin Yan, et al.
iMeta (2024) Vol. 3, Iss. 4
Open Access | Times Cited: 7
Jing Li, Siyuan Wang, Kaixin Yan, et al.
iMeta (2024) Vol. 3, Iss. 4
Open Access | Times Cited: 7
The Interplay between Gut Microbiota and Oral Medications and Its Impact on Advancing Precision Medicine
Sara Mousa, Muhammad Sarfraz, Walaa K. Mousa
Metabolites (2023) Vol. 13, Iss. 5, pp. 674-674
Open Access | Times Cited: 14
Sara Mousa, Muhammad Sarfraz, Walaa K. Mousa
Metabolites (2023) Vol. 13, Iss. 5, pp. 674-674
Open Access | Times Cited: 14
Resistance to Antihypertensive Drugs: Is Gut Microbiota the Missing Link?
Jun Kyoung, Rohit Atluri, Tao Yang
Hypertension (2022) Vol. 79, Iss. 10, pp. 2138-2147
Closed Access | Times Cited: 19
Jun Kyoung, Rohit Atluri, Tao Yang
Hypertension (2022) Vol. 79, Iss. 10, pp. 2138-2147
Closed Access | Times Cited: 19
The link between immunity and hypertension in the kidney and heart
Lance Benson, Yunping Guo, Katherine Deck, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 11
Lance Benson, Yunping Guo, Katherine Deck, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 11
Underlying Mechanism of Drug and Non-drug Interactions
John I. Ogbu, Caroline V. L. Moreira, Ramiro Saavedra, et al.
(2025), pp. 205-231
Closed Access
John I. Ogbu, Caroline V. L. Moreira, Ramiro Saavedra, et al.
(2025), pp. 205-231
Closed Access
Sexual Dimorphic Interplays Between Gut Microbiota and Antihypertensive Drugs
Pritam Bardhan, Tao Yang
Current Hypertension Reports (2023) Vol. 25, Iss. 8, pp. 163-172
Open Access | Times Cited: 9
Pritam Bardhan, Tao Yang
Current Hypertension Reports (2023) Vol. 25, Iss. 8, pp. 163-172
Open Access | Times Cited: 9
Guidelines for microbiome studies in renal physiology
Rikeish R. Muralitharan, Matthew Snelson, Guillaume Méric, et al.
AJP Renal Physiology (2023) Vol. 325, Iss. 3, pp. F345-F362
Closed Access | Times Cited: 8
Rikeish R. Muralitharan, Matthew Snelson, Guillaume Méric, et al.
AJP Renal Physiology (2023) Vol. 325, Iss. 3, pp. F345-F362
Closed Access | Times Cited: 8
Milestone Papers on Signal Transduction Mechanisms of Hypertension and Its Complications
Satoru Eguchi, Keiichi Torimoto, Adebowale Adebiyi, et al.
Hypertension (2024) Vol. 81, Iss. 5, pp. 977-990
Closed Access | Times Cited: 3
Satoru Eguchi, Keiichi Torimoto, Adebowale Adebiyi, et al.
Hypertension (2024) Vol. 81, Iss. 5, pp. 977-990
Closed Access | Times Cited: 3
Dysbiosis versus diabesity: Pathological signaling and promising therapeutic strategies
Arun K. Sharma, Akash Sharma, Samridhi Lal, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 5, pp. 103558-103558
Closed Access | Times Cited: 7
Arun K. Sharma, Akash Sharma, Samridhi Lal, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 5, pp. 103558-103558
Closed Access | Times Cited: 7
Revitalizing myocarditis treatment through gut microbiota modulation: unveiling a promising therapeutic avenue
Jingyue Wang, Xianfeng Zhang, Xinyu Yang, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 7
Jingyue Wang, Xianfeng Zhang, Xinyu Yang, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 7
Piglet cardiopulmonary bypass induces intestinal dysbiosis and barrier dysfunction associated with systemic inflammation
Jeffrey Salomon, Haowen Qiu, Dan Feng, et al.
Disease Models & Mechanisms (2022) Vol. 16, Iss. 5
Open Access | Times Cited: 12
Jeffrey Salomon, Haowen Qiu, Dan Feng, et al.
Disease Models & Mechanisms (2022) Vol. 16, Iss. 5
Open Access | Times Cited: 12
Sex Differences in Gut Microbiota, Hypertension, and Cardiovascular Risk
Anish Sharma, Sahil K. Kapur, Priyal Kancharla, et al.
European Journal of Pharmacology (2024), pp. 177183-177183
Closed Access | Times Cited: 2
Anish Sharma, Sahil K. Kapur, Priyal Kancharla, et al.
European Journal of Pharmacology (2024), pp. 177183-177183
Closed Access | Times Cited: 2
Genetically engineered Lactobacillus paracasei rescues colonic angiotensin converting enzyme 2 (ACE2) and attenuates hypertension in female Ace2 knock out rats
Xue Mei, Blair Mell, Sachin Aryal, et al.
Pharmacological Research (2023) Vol. 196, pp. 106920-106920
Open Access | Times Cited: 6
Xue Mei, Blair Mell, Sachin Aryal, et al.
Pharmacological Research (2023) Vol. 196, pp. 106920-106920
Open Access | Times Cited: 6
Subdiaphragmatic vagal nerve stimulation attenuates the development of hypertension and alters nucleus of the solitary tract transcriptional networks in the spontaneously hypertensive rat
Elliott W. Dirr, Ladan G. Jiracek, David M. Baekey, et al.
Physiological Genomics (2023) Vol. 55, Iss. 12, pp. 606-617
Open Access | Times Cited: 5
Elliott W. Dirr, Ladan G. Jiracek, David M. Baekey, et al.
Physiological Genomics (2023) Vol. 55, Iss. 12, pp. 606-617
Open Access | Times Cited: 5
Antihypertensives and Antibiotics: Impact on Intestinal Dysfunction and Hypertension
Sarah Lucas, Sarah L. Walton, Katrina M. Mirabito Colafella, et al.
Hypertension (2023) Vol. 80, Iss. 7, pp. 1393-1402
Closed Access | Times Cited: 4
Sarah Lucas, Sarah L. Walton, Katrina M. Mirabito Colafella, et al.
Hypertension (2023) Vol. 80, Iss. 7, pp. 1393-1402
Closed Access | Times Cited: 4
Chronotropic and vasoactive properties of the gut bacterial short-chain fatty acids in larval zebrafish
Hemaa Sree Kumar, Alexander Wisner, Isaac T. Schiefer, et al.
Physiological Genomics (2024) Vol. 56, Iss. 6, pp. 426-435
Open Access | Times Cited: 1
Hemaa Sree Kumar, Alexander Wisner, Isaac T. Schiefer, et al.
Physiological Genomics (2024) Vol. 56, Iss. 6, pp. 426-435
Open Access | Times Cited: 1
Differing contributions of the gut microbiota to the blood pressure lowering effects induced by first‐line antihypertensive drugs
Cristina González‐Correa, Javier Moleón, Sofía Miñano, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 18, pp. 3420-3444
Open Access | Times Cited: 1
Cristina González‐Correa, Javier Moleón, Sofía Miñano, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 18, pp. 3420-3444
Open Access | Times Cited: 1
Intestinal serotonergic vagal signaling as a mediator of microbiota-induced hypertension
Alan de Araujo, Hemaa Sree Kumar, Tao Yang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Alan de Araujo, Hemaa Sree Kumar, Tao Yang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Oxidative Stress in Kidney Injury and Hypertension
William J. Arendshorst, Aleksandr E. Vendrov, Nitin Kumar, et al.
Antioxidants (2024) Vol. 13, Iss. 12, pp. 1454-1454
Open Access | Times Cited: 1
William J. Arendshorst, Aleksandr E. Vendrov, Nitin Kumar, et al.
Antioxidants (2024) Vol. 13, Iss. 12, pp. 1454-1454
Open Access | Times Cited: 1
Host‐Microbiota Communication in Spontaneously Hypertensive Rats Generates Unique IgA‐Coated Gut Microbes
Jing Li, Elaine M. Richards, Ramakumar Tummala, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 4
Open Access | Times Cited: 3
Jing Li, Elaine M. Richards, Ramakumar Tummala, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 4
Open Access | Times Cited: 3